The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
|Articles|December 9, 2022
News Roundup: December 5 to December 9
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Pharmacist Involvement Has Positive Impact on Patients Receiving Gender Affirming Care
Pharmacists can optimize medication adherence and serve as an additional touchpoint for patients during treatment.
Creating A Career Ladder for Pharmacy Technicians
Developing more advanced roles for pharmacy technician can reduce turnover in roles.
Representation Matters: Improving Diversity in Pharmacy
Ann Anaya and Dean Kathleen Kennedy discuss the importance of diversity in pharmacy and why it matters that patients are treated by someone who looks like them. Plus, Good Neighbor Pharmacy launches a scholarship program to help address these needs.
Pharmacist Intervention Improves Clinical Outcomes in Patients with Diabetes
Diabetes self-management education and diabetes prevention programs can improve patient outcomes including mental health and HbA1C.
Multidisciplinary Stakeholder Approach Successful in Managing Limited COVID-19 Treatment Resources
Two clinical pathways were created to manage patients and required resources.
Advertisement
Related to this article
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
4
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
5